CureVac
More News
-
GSK, CureVac team up to develop vaccine against Covid-19 variants
Both GSK & CureVac have teamed up in 150 million euro ($180 million) deal to develop a vaccine targeting new variants
-
Bill Gates predicts 'the rich world' will likely end pandemic sooner
Bill Gates has criticised US testing system and Trump administration for the way they have dealt with Covid-19 crisis
